Jane Street’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,026
Closed -$257K 12827
2025
Q4
$257K Buy
+5,026
New +$232K ﹤0.01% 9179
2025
Q1
Sell
-7,444
Closed -$246K 10459
2024
Q4
$246K Sell
7,444
-2,351
-24% -$88.7K ﹤0.01% 8066
2024
Q3
$366K Buy
+9,795
New +$357K ﹤0.01% 7715
2022
Q2
Sell
-6,189
Closed -$208K 10720
2022
Q1
$208K Buy
+6,189
New +$214K ﹤0.01% 8983
2019
Q4
Sell
-22,540
Closed -$711K 5662
2019
Q3
$711K Buy
22,540
+10,279
+84% +$361K ﹤0.01% 3052
2019
Q2
$443K Buy
+12,261
New +$423K ﹤0.01% 3735
2019
Q1
Sell
-45,372
Closed -$1.28M 5547
2018
Q4
$1.28M Sell
45,372
-35,272
-44% -$1.17M ﹤0.01% 2241
2018
Q3
$3.17M Buy
+80,644
New +$3.06M 0.01% 1442
2018
Q2
Sell
-18,539
Closed -$635K 5530
2018
Q1
$635K Buy
+18,539
New +$650K ﹤0.01% 3193
2017
Q2
Sell
-23,855
Closed -$615K 4803
2017
Q1
$615K Sell
23,855
-21,778
-48% -$542K ﹤0.01% 2635
2016
Q4
$1.05M Buy
45,633
+35,913
+369% +$860K ﹤0.01% 2013
2016
Q3
$254K Sell
9,720
-13,911
-59% -$347K ﹤0.01% 3469
2016
Q2
$535K Buy
23,631
+12,839
+119% +$305K ﹤0.01% 2700
2016
Q1
$237K Sell
10,792
-7,041
-39% -$161K ﹤0.01% 3500
2015
Q4
$566K Sell
17,833
-35,673
-67% -$1.09M ﹤0.01% 2345
2015
Q3
$1.49M Sell
53,506
-54,885
-51% -$1.92M 0.01% 1238
2015
Q2
$3.85M Buy
108,391
+65,911
+155% +$2.15M 0.02% 592
2015
Q1
$1.27M Buy
+42,480
New +$1.19M 0.01% 1193

Other funds holding SBIO

Jane Street's SBIO Position: Q1 2026 in Review

Jane Street sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026, closing a stake of 5,026 shares — an estimated $257K sold.

Jane Street first reported a position in SBIO in Q1 2015 and held it in 18 quarters. The position peaked at $3.85M in Q2 2015. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Jane Street reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 5,026 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $257K.
  • Jane Street first reported a position in ALPS Medical Breakthroughs ETF in Q1 2015 and held it in 18 quarters.
  • Jane Street's ALPS Medical Breakthroughs ETF position peaked at $3.85M in Q2 2015.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.